[Effects of hexamethylenebisacetamide on the differentiation of embryonal carcinoma cells].
HMBA induces differentiation in the whole population of some multipotential embryonic carcinoma cells. Morphological, biochemical and immunological changes can be observed even after short treatment. The cells lose the embryonal F9 antigen without acquiring H-2 antigens.
D000081:Acetamides / Q000494:pharmacology*; D000199:Actins / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000032:analysis; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D003959:Diamines / Q000494:pharmacology*; D010960:Plasminogen Activators / Q000378:metabolism; D013539:Simian virus 40; D013724:Teratoma / Q000473:pathology* / Q000503:physiopathology; D014779:Virus Replication / Q000187:drug effects
D000081:Acetamides; D000199:Actins; D000951:Antigens, Neoplasm; D003959:Diamines; D000469:Alkaline Phosphatase; D010960:Plasminogen Activators
Effets de l'hexaméthylènebisacétamide sur la différenciation de cellules de carcinome embryonnaire.